Stay updated on Sparsentan in IgA Nephropathy: Clinical Trial

Sign up to get notified when there's something new on the Sparsentan in IgA Nephropathy: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sparsentan in IgA Nephropathy: Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added a new publication citation under Publications: 'Association between Complete Proteinuria Remission and Kidney Function in the Phase 3 PROTECT Trial of Sparsentan in IgA Nephropathy' (Clin J Am Soc Nephrol, 2025).
    Difference
    0.0%
    Check dated 2026-02-19T04:42:23.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; no visible changes to core content or layout were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T02:14:25.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision: v3.4.1 replaces the previous v3.4.0, which appears to be a minor version update with no impact on study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T23:07:03.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). Removed older wording (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).
    Difference
    0.1%
    Check dated 2026-01-28T20:02:28.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4; no visible changes to core study content are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:42:12.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added new trial locations across the United States, Australia, and Europe and removed several existing locations, altering the geographic availability of study sites. This affects where participants can enroll and access the trial.
    Difference
    3%
    Check dated 2025-12-23T20:27:56.000Z thumbnail image

Stay in the know with updates to Sparsentan in IgA Nephropathy: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sparsentan in IgA Nephropathy: Clinical Trial page.